Education
About Us
Working with TipRanks
Follow Us
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
MBOT Stock Chart & Stats
$1.84
-$1.10(-38.87%)
At close: 4:00 PM EST
$1.84
-$1.10(-38.87%)
Day’s Range― - ―
52-Week Range$1.25 - $4.67
Previous CloseN/A
Volume6.51M
Average Volume (3M)1.08M
Market Cap
$123.57M
Enterprise Value$81.46M
Total Cash (Recent Filing)$80.16M
Total Debt (Recent Filing)$899.00K
Price to Earnings (P/E)―
Beta1.79
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding67,158,040
10 Day Avg. Volume1,198,609
30 Day Avg. Volume1,080,660
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)4.96
Price to Sales (P/S)0.00
P/FCF Ratio-1.98
Enterprise Value/Market Cap0.66
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.70K
Enterprise Value/Ebitda-6.07
Forecast
1Y Price Target
$7.50Price Target Upside307.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.34
Revenue Forecast (FY)$4.29M
Bulls Say, Bears Say
Bulls Say
Clinical Performance And Physician AcceptanceSystem showed strong physician satisfaction while substantially lowering radiation exposure and operator strain, supporting clinical adoption and procedural efficiency.
Intellectual Property And Funding For RolloutPatents granted in key markets and stated capital sufficiency support the commercial roll-out and help defend technology versus competitors while enabling aggressive pricing to encourage uptake.
Regulatory Approval And Limited Commercial LaunchFDA clearance and limited commercial availability in select U.S. hospitals provides a first-mover position in peripheral endovascular robotic procedures.
Bears Say
Commercialization Execution RiskDelays in scaling beyond a limited release or setbacks in commercialization execution could impede revenue growth and dampen market sentiment.
Market Adoption And Competitive PressureSlower-than-expected uptake due to market size constraints, penetration challenges, or competing alternatives may limit achievable market share.
Profitability And Indication Expansion UncertaintyFailure to expand into cardiac and neuro applications combined with continued lack of near-term profitability increases the risk of prolonged cash burn and valuation pressure.
Microbot Medical News
MBOT FAQ
What was Microbot Medical Inc’s price range in the past 12 months?
Microbot Medical Inc lowest stock price was $1.25 and its highest was $4.67 in the past 12 months.
What is Microbot Medical Inc’s market cap?
Microbot Medical Inc’s market cap is $123.57M.
When is Microbot Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical Inc’s earnings last quarter?
Currently, no data Available
Is Microbot Medical Inc overvalued?
According to Wall Street analysts Microbot Medical Inc’s price is currently Undervalued.
Does Microbot Medical Inc pay dividends?
Microbot Medical Inc does not currently pay dividends.
What is Microbot Medical Inc’s EPS estimate?
Microbot Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical Inc have?
Microbot Medical Inc has 67,158,040 shares outstanding.
What happened to Microbot Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Microbot Medical Inc?
Currently, no hedge funds are holding shares in MBOT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Microbot Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.50 (307.61% Upside)
$7.50 (307.61% Upside)
Blogger Sentiment
Neutral
MBOT Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 8.4%
Last 30 Days ▼ 8.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.84%
12-Months-Change
Fundamentals
Return on Equity
-31.87%
Trailing 12-Months
Asset Growth
1469.89%
Trailing 12-Months
Company Description
Microbot Medical Inc
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
MBOT Stock 12 Month Forecast
Average Price Target
$7.50
▲(307.61% Upside)
Technical Analysis
Ownership Overview
0.20%
Insiders
3.79% Mutual Funds
3.84% Other Institutional Investors
88.71% Public Companies and
Individual Investors